Iolyx Therapeutics Announces Promising Phase II Results for ILYX-002 in Autoimmune Dry Eye Disease
ILYX-002 shows 3x greater corneal healing effect compared to current therapies on the market. Iolyx Therapeutics (California, United States), a…
WOS 2025: A Spectacle of Science, Surgery and Swiss Charm
Winterthur wows again! The 2nd WOS dazzled the eye care world with cutting-edge ophthalmology and Swiss flair. The 2nd Winterthur…
latest posts
